NCT00547378 - InSite for Over Active Bladder | Biotech Hunter

Enrollment

571

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Urinary Incontinence, Urgency-frequencyOveractive Bladder

Interventions

DEVICE

InterStim

DRUG

Standard Medical Therapy

Oxybutynin 2.5mg, 5mg Oxybutynin extended release 5 mg, 10mg, 15mg Oxybutynin transdermal 3.9mg Solifenacin 5mg, 10mg Tolterodine 1mg, 2mg Tolterodine extended release 2mg, 4mg Trospium 20mg Darifenacin extended release 7.5mg, 15mg fesoterodine Fumarate 4mg, 8mg